- Home
- XPON vs SXTP Comparison
XPON vs SXTP Comparison
Compare XPON & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- SXTP
- Stock Information
- Founded
- XPON 2016
- SXTP 2010
- Country
- XPON United States
- SXTP United States
- Employees
- XPON N/A
- SXTP N/A
- Industry
- XPON Electronic Components
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- SXTP Health Care
- Exchange
- XPON Nasdaq
- SXTP Nasdaq
- Market Cap
- XPON 3.8M
- SXTP 3.4M
- IPO Year
- XPON 2022
- SXTP 2023
- Fundamental
- Price
- XPON $1.85
- SXTP $1.32
- Analyst Decision
- XPON
- SXTP Buy
- Analyst Count
- XPON 0
- SXTP 2
- Target Price
- XPON N/A
- SXTP $7.00
- AVG Volume (30 Days)
- XPON 21.1M
- SXTP 152.7K
- Earning Date
- XPON 08-13-2025
- SXTP 08-13-2025
- Dividend Yield
- XPON N/A
- SXTP N/A
- EPS Growth
- XPON N/A
- SXTP N/A
- EPS
- XPON N/A
- SXTP N/A
- Revenue
- XPON $8,414,250.00
- SXTP $984,494.00
- Revenue This Year
- XPON $61.26
- SXTP $81.41
- Revenue Next Year
- XPON N/A
- SXTP $95.63
- P/E Ratio
- XPON N/A
- SXTP N/A
- Revenue Growth
- XPON 68.33
- SXTP 128.70
- 52 Week Low
- XPON $0.60
- SXTP $1.24
- 52 Week High
- XPON $22.81
- SXTP $12.70
- Technical
- Relative Strength Index (RSI)
- XPON 70.99
- SXTP 34.65
- Support Level
- XPON $1.08
- SXTP $1.24
- Resistance Level
- XPON $5.50
- SXTP $1.40
- Average True Range (ATR)
- XPON 0.36
- SXTP 0.09
- MACD
- XPON 0.06
- SXTP 0.04
- Stochastic Oscillator
- XPON 17.42
- SXTP 41.03
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.